Abstract
Repeated, low-dose administration of streptozotocin (STZ) is widely used to induce insulin-dependent diabetes mellitus in mice. The authors adapted this method using neonatal mice and determined the long-term effects of STZ injection in the mice. After receiving intraperitoneal injections of STZ at postnatal day 3 (P3), P4 and P8, male and female mice were hyperglycemic by week 4. A clear sex difference was found, with blood glucose levels in STZ-treated males remaining higher than those in STZ-treated females until week 23. Whereas STZ-treated males remained hyperglycemic until week 23, STZ-treated females did not have significantly higher glucose levels than control mice after week 18. Additionally, STZ-treated mice had neoplastic lesions in their livers by week 4, with a progression in the severity of these lesions until week 24. The results confirm that, in addition to pancreatic beta cell toxicity, STZ has an oncogenic effect on the liver when administered to neonates.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
We are sorry, but there is no personal subscription option available for your country.
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bolzán, A.D. & Bianchi, M.S. Genotoxicity of streptozotocin. Mutat. Res. 512, 121–134 (2002).
Rakieten, N., Rakieten, M.L. & Nadkarni, M.V. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother. Rep. 29, 91–98 (1963).
Schnedl, W.J., Ferber, S., Johnson, J.H. & Newgard, C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43, 1326–1333 (1994).
Deeds, M.C. et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45, 131–140 (2011).
Saini, K.S., Thompson, C., Winterford, C.M., Walker, N.I. & Cameron, D.P. Streptozotocin at low doses induces apoptosis and at high doses causes necrosis in a murine pancreatic β-cell line, INS-1. Biochem. Mol. Biol. Int. 39, 1229–1236 (1996).
Rossini, A.A., Appel, M.C., Williams, R.M. & Like, A.A. Genetic influence of the streptozotocin-induced insulitis and hyperglycemia. Diabetes 26, 916–920 (1977).
Like, A.A. & Rossini, A.A. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417 (1976).
Ito, M., Kondo, Y., Nakatani, A. & Naruse, A. New model of progressive non-insulin-dependent diabetes mellitus in mice induced by streptozotocin. Biol. Pharm. Bull. 22, 988–989 (1999).
Pelegrin, M. et al. Evidence from transgenic mice that interferon-β may be involved in the onset of diabetes mellitus. J. Biol. Chem. 273, 12332–12340 (1998).
Otaegui, P.J. et al. Expression of glucokinase in skeletal muscle: a new approach to counteract diabetic hyperglycemia. Hum. Gene Ther. 11, 1543–1552 (2000).
Mas, A. et al. Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle. Diabetes 55, 1546–1553 (2006).
Cunha, A.R., Aguila, M.B. & Mandarim-de-Lacerda, C.A. Effects of early postnatal hyperglycaemia on renal cortex maturity, endothelial nitric oxide synthase expression and nephron deficit in mice. Int. J. Exp. Pathol. 89, 284–291 (2008).
Ariza, L. et al. Inducción de diabetes experimental por administracción de estreptozotocina a ratones neonatos [Spanish]. Proceedings of the XI National Congress of the Spanish Society for Laboratory Animal Science, Valencia, Spain, 22–25 November 2011.
Kataoka, M. et al. Recovery from diabetes in neonatal mice after a low-dose streptozotocin treatment. Biochem. Biophys. Res. Commun. 430, 1103–1108 (2013).
Hartmann, K., Besch, W. & Zühlke, H. Spontaneous recovery of streptozotocin diabetes in mice. Exp. Clin. Endocrinol. 93, 225–230 (1989).
Le May, C. et al. Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. USA 103, 9232–9237 (2006).
Ernst, S., Demirci, C., Valle, S., Velasquez-Garcia, S. & Garcia-Ocaña, A. Mechanisms in the adaptation of maternal β-cells during pregnancy. Diabetes Manag. (Lond.) 1, 239–248 (2011).
Toth, B. A critical review of experiments in chemical carcinogenesis using newborn animals. Cancer Res. 28, 727–738 (1968).
Arison, R.N. & Feudale, E.L. Induction of renal tumour by streptozotocin in rats. Nature 214, 1254–1255 (1967).
Rakieten, N., Gordon, B.S., Cooney, D.A., Davis, R.D. & Schein, P.S. Renal tumorigenic action of streptozotocin (NSC-85998) in rats. Cancer Chemother. Rep. 52, 563–567 (1968).
Rakieten, N. et al. Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proc. Soc. Exp. Biol. Med. 137, 280–283 (1971).
Rakieten, N. et al. Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Proc. Soc. Exp. Biol. Med. 151, 356–361 (1976).
Iwase, M., Nunoi, K., Sadoshima, S., Kikuchi, M. & Fujishima, M. Liver, kidney and islet cell tumors in spontaneously hypertensive and normotensive rats treated neonatally with streptozotocin. Tohoku J. Exp. Med. 159, 83–90 (1989).
Sibay, T.M. & Hayes, J.A. Potential carcinogenic effect of streptozotocin. Lancet 2, 912 (1969).
Weisburger, J.H. et al. The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy. Recent Results Cancer Res. 52, 1–17 (1975).
Berman, L.D., Hayes, J.A. & Sibay, T.M. Effect of streptozotocin in the Chinese hamster (Cricetulus griseus). J. Natl. Cancer Inst. 51, 1287–1294 (1973).
Hard, G.C. Identification of a high-frequency model for renal carcinoma by the induction of renal tumors in the mouse with a single dose of streptozotocin. Cancer Res. 45, 703–708 (1985).
Gruys, M.E. et al. Induction of transplantable mouse renal cell cancers by streptozotocin: in vivo growth, metastases, and angiogenic phenotype. Cancer Res. 61, 6255–6263 (2001).
Beppu, T. et al. High incidence of tumors in diabetic thrombin activatable fibrinolysis inhibitor and apolipoprotein E double-deficient mice. J. Thromb. Haemost. 8, 2514–2522 (2010).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Ariza, L., Zaguirre, M., García, M. et al. Hyperglycemia and hepatic tumors in ICR mice neonatally injected with streptozotocin. Lab Anim 43, 242–249 (2014). https://doi.org/10.1038/laban.530
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/laban.530
This article is cited by
-
Sex differences in glucose metabolism of streptozotocin-induced diabetes inbred mice (C57BL/6J)
Applied Biological Chemistry (2020)